Skip to Content
  • Niemann-Pick Type C
    • Research
    • General Grant Guidelines
    • Resources
    • Links
  • Get Involved
  • About DART
    • Our Leadership
    • A Tribute to Dana
    • DART Documents
    • Contact DART
  • Past Events
  • News Blog
  • Upcoming Events
  • Press Info
  • Donate Now
Dana's Angels Research Trust (DART)

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust for Niemann-Pick

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust for Niemann-Pick

  • Niemann-Pick Type C
    • Research
    • General Grant Guidelines
    • Resources
    • Links
  • Get Involved
  • About DART
    • Our Leadership
    • A Tribute to Dana
    • DART Documents
    • Contact DART
  • Past Events
  • News Blog
  • Upcoming Events
  • Press Info
  • Donate Now
Announcements Banner News Niemann-Pick Type C News Research News

Mandos Submits New Drug Application to U.S. FDA for Adrabetadex in Infantile-Onset NPC!

Announcements Banner News Niemann-Pick Type C News Research News

Adrabetadex (Cyclodextrin) receives FDA Breakthrough Therapy Designation for Individuals with Infantile-Onset NPC

Announcements Banner News DART News DART Walk/Run

2025 Annual DART to the Finish Charity Walk Raises Over $160,000

Banner News Niemann-Pick Type C News Research News

Great Data On Adrabetadex/Cyclodextrin Released By Mandos Health

Banner News Research News

Azafaros Secures €132M in Financing to advance Phase 3 clinical programs, including NPC

Banner News Niemann-Pick Type C News Research News

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million related to NPC drug approval

Announcements Banner News Niemann-Pick Type C News Research News

FDA Approves 2nd New Drug to Treat NPC

Announcements Banner News Niemann-Pick Type C News Research News

FDA Approves 1st Treatment for NPC

Banner News Niemann-Pick Type C News Research News

FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients

Announcements DART News Niemann-Pick Type C News

Research Update – June 2010

DART and 4 other NPC family foundations continue their support of the SOAR-NPC collaborative effort.  SOAR-NPC is in essence a virtual biotech, pharmaceutical enterprise seeking a drug cocktail to arrest the progression of NPC.  In September 2009, at the National Institutes of Health, SOAR-NPC’s team was able to initiate its first human trial, and only …

Read more
June 1, 2010January 12, 2011
Benefit Concert Past DART Events

Smokey Robinson Gala raises over $325,000!

On Friday, May 14, 2010, at the Palace Theatre in Stamford, CT, the Grammy Award® winning member  of the Rock and Roll Hall of Fame,  Kennedy Center honoree, and “King of Motown”, SMOKEY ROBINSON thrilled over 1,000 fans with stories of Motown and some of his 70 Top-40 hits like  BEING WITH YOU, OOH BABY BABY, JUST …

Read more
May 28, 2010October 9, 2012
Niemann-Pick Type C News Research News

FDA rejects Zavesca panel recommendation.

Unfortunately, in mid-March the FDA advised pharmaceutical company Actelion, which markets Zavesca that they would not yet approve Zavesca for NPC; that more definitive proof is required by the law. We are hopeful that further study efforts will lead to future approval. The consequence of the FDA’s decision is that too many children with NPC …

Read more
March 27, 2010February 8, 2021

Posts navigation

Older posts
Newer posts
Donate Now

Donate Now

Shop Now

Read Past Posts

Dana's Angels Research Trust
15 E. Putnam Avenue, #117
Greenwich, CT 06830-5424
Telephone: 1-203-861-2063
FAX 1-203-861-1522
email us info@danasangels.org
Copyright Dana's Angels Research Trust 2002-2022, All rights reserved Blossom PinThis | Developed By Blossom Themes. Powered by WordPress.